info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Syphilis Testing Market Research Report: By Sample Type (Blood, Serum, Plasma, Cerebrospinal Fluid), By Technology (Enzyme Immunoassay (EIA), Chemiluminescence Immunoassay (CLIA), Rapid Plasma Reagin (RPR) Test, Treponema Pallidum Particle Agglutination (TPPA) Test, Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test), By Product Type (Automated Syphilis Testing Systems, Manual Syphilis Testing Kits, Point-of-Care Syphilis Testing Devices), By Application (Diagnostic Testing, Screening and Surveillance, Monitoring of Treatment Respons


ID: MRFR/HC/26206-HCR | 100 Pages | Author: Rahul Gotadki| October 2024

Global Syphilis Testing Market Overview


As per MRFR analysis, the Syphilis Testing Market Size was estimated at 1.0 (USD Billion) in 2022. 

The Syphilis Testing Market Industry is expected to grow from 1.03(USD Billion) in 2023 to 1.4 (USD Billion) by 2032. The Syphilis Testing Market CAGR (growth rate) is expected to be around 3.46% during the forecast period (2024 - 2032).


Key Syphilis Testing Market Trends Highlighted


Emerging molecular diagnostics and advancements in serological testing methods drive the Syphilis Testing Market. The increasing prevalence of sexually transmitted infections (STIs), including syphilis, fuels market growth. Furthermore, advancements in point-of-care (POC) testing offer rapid and accurate syphilis detection, enhancing market adoption.Government initiatives and public health campaigns to combat STIs create opportunities for market expansion. Collaborations between governments and healthcare organizations to provide affordable syphilis testing and treatment programs drive market growth. Additionally, technological advancements in automation and multiplex testing systems streamline testing procedures, reducing turnaround time and costs.The market has witnessed the emergence of non-invasive testing methods, such as oral fluid and urine testing, which provide convenient and less invasive alternatives to traditional blood tests. This trend expands testing accessibility and facilitates early detection and treatment of syphilis, contributing to market growth.


Syphilis Testing Market Overview


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Syphilis Testing Market Drivers


Rising Incidence of Syphilis Infections


The growth in the Syphilis Testing Market Industry is primarily driven by the increasing prevalence of syphilis infections. Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. It can affect both men and women and if left untreated, it can cause serious health problems. According to the World Health Organization, there were an estimated 6.3 million new cases of syphilis in 2020. The growing number of infections is a result of several factors, including unprotected sex, lack of information about the disease and limited access to medical help.Because the number of people suffering from syphilis continues to grow, the demand for syphilis testing is expected to increase.


Technological Advancements in Syphilis Testing


Technological advancement in syphilis testing is driving the Syphilis Testing Market Industry. Conventionally, the Venereal Disease Research Laboratory and Treponema pallidum particle agglutination tests have been used to test syphilis for many years. These tests have been found to have some limitations, such as low sensitivity and specificity. However, over the years, new technologies for testing Syphilis have been developed which are more accurate.These technological tests include rapid point-of-care testing, nucleic acid amplification testing, and multiplex assays. Future growth in the Syphilis Testing Market Industry will depend on whether more people will adopt these new tests for syphilis or not.


Increasing Awareness about Syphilis


The Syphilis Testing Market Industry is further helped due to the growing awareness of the disease. A number of public health campaigns and programs are being run to prevent the disease and to educate the masses about the problems associated with the same. This growing awareness is creating a demand for more and more syphilis tests, thus contributing to the growth of the market. People are now more aware of the easy availability of testing facilities.The availability of self-test kits and other resources has made it easier and more confidential for people to get themselves tested. Thus, the Syphilis Testing Market Industry is being driven due to the increasing awareness created about the issue.


Syphilis Testing Market Segment Insights


Syphilis Testing Market Sample Type Insights


The report “Syphilis Testing Market Forecasts to 2032” provides an in-depth analysis of the Syphilis Testing Market. The market is segmented by sample type. Based on sample type, the market is segmented into whole blood, serum, plasma and cerebrospinal fluid. The whole blood segment is expected to hold the largest market share for 2023. The serum segment is expected to grow at the highest CAGR in the forecast period. The growth of the syphilis testing market can be attributed to increasing prevalence of syphilis, technological advancements in syphilis testing methods and rising awareness about syphilis testing.The market is also expected to benefit from the increasing availability of syphilis testing kits and the increasing number of diagnostic centers.


Syphilis Testing Market Sample Type Insights


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Syphilis Testing Market Technology Insights


Enzyme Immunoassay was the technology with the largest share in the Syphilis Testing Market in 2023 and is expected to continue to lead the market over the forecast period. EIA is a widely used technology due to its high sensitivity, specificity, and relatively low cost. Chemiluminescence Immunoassay is another common technology that provides the benefits of rapid results and automated testing. Rapid Plasma Reagin is a relatively simple and inexpensive test that is often used for screening purposes. Treponema Pallidum Particle Agglutination Test and Fluorescent Treponemal Antibody Absorption Test are more expensive confirmatory tests that are used to make a highly accurate diagnosis of syphilis.


Syphilis Testing Market Product Type Insights


The Syphilis Testing Market segmentation by Product Type presents valuable insights into the market dynamics. Automated Syphilis Testing Systems, Manual Syphilis Testing Kits, and Point-of-Care Syphilis Testing Devices represent the key product types. Automated Syphilis Testing Systems accounted for the largest revenue share in 2023, attributed to their high accuracy and efficiency in processing a large number of samples. The Syphilis Testing Market data shows that Automated Syphilis Testing Systems are expected to maintain their dominance throughout the forecast period, driven by advancements in technology and increased demand for automated solutions.Manual Syphilis Testing Kits are projected to witness steady growth, primarily due to their cost-effectiveness and availability in resource-limited settings. However, their market share is anticipated to decline gradually as automated systems become more prevalent. Point-of-Care Syphilis Testing Devices are gaining traction owing to their rapid turnaround time and convenience. The Syphilis Testing Market Statistics indicate that this segment is poised for significant growth, particularly in regions with limited access to laboratory infrastructure.By leveraging these insights, market players can strategize their product offerings and target specific segments to drive growth and capture a larger share of the Syphilis Testing Market industry.


Syphilis Testing Market Application Insights


The Syphilis Testing Market is segmented by application into diagnostic testing, screening and surveillance, and monitoring of treatment response. The diagnostic testing segment is expected to hold the largest market share in 2023 and is projected to continue to dominate the market throughout the forecast period. This is due to the increasing prevalence of syphilis, as well as the need for accurate and timely diagnosis to prevent serious complications. The screening and surveillance segment is expected to grow at a rapid pace due to the increasing adoption of syphilis screening programs in high-risk populations.The monitoring of the treatment response segment is expected to grow at a moderate pace due to the increasing use of serological tests to monitor the effectiveness of syphilis treatment.


Syphilis Testing Market End User Insights


The Syphilis Testing Market is segmented by end user into diagnostic laboratories, hospitals and clinics, research institutions, blood banks, and point-of-care facilities. Among these, diagnostic laboratories held the largest market share in 2023 and are expected to maintain their dominance throughout the forecast period. This is attributed to the increasing number of syphilis cases, growing awareness about the disease, and the availability of advanced testing technologies in diagnostic laboratories. Hospitals and clinics are also expected to witness significant growth in the coming years, owing to the increasing number of patients seeking syphilis testing and the rising prevalence of the disease in developing countries.Research institutions are also expected to contribute to the growth of the market, as they are involved in the development of new and innovative syphilis testing methods. Blood banks and point-of-care facilities are also expected to experience growth as they provide convenient and accessible testing options for patients.


Syphilis Testing Market Regional Insights


The Syphilis Testing Market is segmented by region into North America, Europe, APAC, South America and MEA. Among these regions, North America held the largest market share of 38.4% in 2023 and is expected to maintain its dominance throughout the forecast period. This can be attributed to the increasing prevalence of syphilis, coupled with the presence of a well-established healthcare infrastructure in the region. Europe is expected to follow North America in terms of market size, with a revenue share of approximately 30.5% in 2023. The market in APAC is anticipated to witness the highest growth rate over the forecast period, owing to the increasing awareness about syphilis and the availability of affordable testing options in the region.


Syphilis Testing Market Regional Insights


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Syphilis Testing Market Key Players And Competitive Insights


Key companies operating in the Syphilis Testing Market are continuously concentrating on gaining a competitive advantage by investing in research and development, expanding product offerings, and acquiring others. In addition, the major market players are adopting various growth strategies like collaboration, mergers and acquisitions, and joint ventures, which are expected to up the overall competition of the market in the coming years. However, the competitive landscape of the Syphilis Testing Market is anticipated to remain dynamic in the near future, as new players are due to enter the market with innovative solutions to compete with the established players.One of the leading players in the Syphilis Testing Market is Abbott Laboratories. The company offers a broad range of syphilis testing solutions, including rapid tests, automated immunoassays, and molecular diagnostics. Abbott Laboratories has a strong presence across the globe and is in a strong position to leverage the growing demand for syphilis testing. Further, the company is actively focusing on expanding its research and development activities, as it has recently introduced a range of new products to cater to the evolving demands of the market.A key player in the Syphilis Testing Market is Bio-Rad Laboratories, as well. The company provides an extensive product range for syphilis tests, including rapid tests, ELISA kits and molecular diagnostics. Bio-Rad Laboratories has an acute focus on innovation and puts considerable efforts towards offering high-quality products to cater to its client base. Additionally, with an established distribution network, the company is well-placed to meet the increasing demand for syphilis testing across both developed as well as emerging markets.


Key Companies in the Syphilis Testing Market Include



  • Danaher

  • Hologic

  • Chembio Diagnostics

  • QIAGEN

  • BD

  • DiaSorin

  • Jant

  • Siemens Healthineers

  • HoffmannLa Roche

  • Abbott

  • Fujirebio

  • CerTest Biotec

  • BioRad Laboratories

  • Luminex Corporation

  • Meridian Bioscience


Syphilis Testing Market Industry Developments


The Syphilis Testing Market is expected to grow from USD 1.03 billion in 2023 to USD 1.4 billion by 2032, at a CAGR of 3.46%. The market growth is attributed to increasing prevalence of syphilis, technological advancements in testing methods, and rising awareness about the disease.Recent news developments include the launch of new rapid diagnostic tests for syphilis, such as the SD Bioline Syphilis 3.0 Rapid Test. This test provides results in 15 minutes, which is significantly faster than traditional tests. Additionally, there is growing interest in the use of point-of-care syphilis testing, which can be performed in non-traditional settings such as community clinics and pharmacies. This is expected to increase access to testing and improve the early detection and treatment of syphilis.


Syphilis Testing Market Segmentation Insights


Syphilis Testing Market Sample Type Outlook



  • Blood

  • Serum

  • Plasma

  • Cerebrospinal Fluid


Syphilis Testing Market Technology Outlook



  • Enzyme Immunoassay (EIA)

  • Chemiluminescence Immunoassay (CLIA)

  • Rapid Plasma Reagin (RPR) Test

  • Treponema Pallidum Particle Agglutination (TPPA) Test

  • Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test


Syphilis Testing Market Product Type Outlook



  • Automated Syphilis Testing Systems

  • Manual Syphilis Testing Kits

  • Point-of-Care Syphilis Testing Devices


Syphilis Testing Market Application Outlook



  • Diagnostic Testing

  • Screening and Surveillance

  • Monitoring of Treatment Response


 Syphilis Testing Market End User Outlook



  • Diagnostic Laboratories

  • Hospitals and Clinics

  • Research Institutions

  • Blood Banks

  • Point-of-Care Facilities


Syphilis Testing Market Regional Outlook



  • North America

  • Europe

  • South America

  • Asia Pacific

  • Middle East and Africa

Report Attribute/Metric Details
Market Size 2022 1.0(USD Billion)
Market Size 2023 1.03(USD Billion)
Market Size 2032 1.4(USD Billion)
Compound Annual Growth Rate (CAGR) 3.46% (2024 - 2032)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2023
Market Forecast Period 2024 - 2032
Historical Data 2019 - 2023
Market Forecast Units USD Billion
Key Companies Profiled Danaher, Hologic, Chembio Diagnostics, QIAGEN, BD, DiaSorin, Jant, Siemens Healthineers, F. HoffmannLa Roche, Abbott, Fujirebio, CerTest Biotec, BioRad Laboratories, Luminex Corporation, Meridian Bioscience
Segments Covered Sample Type, Technology, Product Type, Application, End User, Regional
Key Market Opportunities Rising prevalence of sexually transmitted infections Technological advancements in testing methods Increasing awareness about syphilis prevention and treatment Expanding access to healthcare services Growing demand for point-of-care diagnostics
Key Market Dynamics Increasing prevalence of technological advancements, rising awareness of government initiatives, favorable reimbursement policies
Countries Covered North America, Europe, APAC, South America, MEA


Frequently Asked Questions (FAQ) :

The Syphilis Testing Market is expected to reach 1.03 billion USD in 2023.

The Syphilis Testing Market is projected to grow at a CAGR of 3.46% from 2024 to 2032.

The Asia Pacific region is expected to hold the largest share of the Syphilis Testing Market in 2032.

The key factors driving the growth of the Syphilis Testing Market include increasing prevalence of syphilis, rising awareness of sexually transmitted diseases, and technological advancements in testing methods.

The major competitors in the Syphilis Testing Market include Abbott Laboratories, bioMérieux, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., and Siemens Healthineers.

The major applications of syphilis testing include screening for syphilis, diagnosing syphilis, and monitoring treatment for syphilis.

The challenges faced by the Syphilis Testing Market include lack of access to testing in some regions, stigma associated with syphilis, and the emergence of antimicrobial resistance.

The opportunities for growth in the Syphilis Testing Market include the development of new and more accurate testing methods, the expansion of testing in underserved regions, and the increasing use of point-of-care testing.

The key trends in the Syphilis Testing Market include the shift towards molecular testing, the increasing use of automation, and the development of rapid and point-of-care testing.

The Syphilis Testing Market is expected to reach 1.4 billion USD in 2032.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.